|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0025202,
umls-concept:C0027651,
umls-concept:C0034897,
umls-concept:C0036525,
umls-concept:C0443252,
umls-concept:C0596545,
umls-concept:C0871261,
umls-concept:C1274040,
umls-concept:C1285530,
umls-concept:C1514474,
umls-concept:C1522449,
umls-concept:C1522484,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1999-6-8
|
|
pubmed:abstractText |
Radiotherapy is used as a "last resort" for patients with advanced cutaneous malignant melanoma. We have analyzed our 20-year clinical experience with respect to different endpoints and prognostic factors in patients with locally advanced, recurrent, or metastatic malignant melanoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
607-18
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10348291-Adult,
pubmed-meshheading:10348291-Aged,
pubmed-meshheading:10348291-Aged, 80 and over,
pubmed-meshheading:10348291-Analysis of Variance,
pubmed-meshheading:10348291-Female,
pubmed-meshheading:10348291-Follow-Up Studies,
pubmed-meshheading:10348291-Humans,
pubmed-meshheading:10348291-Lymphatic Metastasis,
pubmed-meshheading:10348291-Male,
pubmed-meshheading:10348291-Melanoma,
pubmed-meshheading:10348291-Middle Aged,
pubmed-meshheading:10348291-Neoplasm Recurrence, Local,
pubmed-meshheading:10348291-Neoplasm Staging,
pubmed-meshheading:10348291-Palliative Care,
pubmed-meshheading:10348291-Prognosis,
pubmed-meshheading:10348291-Retrospective Studies,
pubmed-meshheading:10348291-Skin Neoplasms,
pubmed-meshheading:10348291-Survival Rate,
pubmed-meshheading:10348291-Treatment Failure
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
|
|
pubmed:affiliation |
The Department of Radiation Oncology, University Erlangen-Nürnberg, Erlangen, Germany.
|
|
pubmed:publicationType |
Journal Article
|
